1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's Disease

Journal of the American Geriatrics Society

Volumn 44, Issue 2, 1996, Pages 133-138

  Parnetti, Lucilla ^a   Lowenthal, David T ^a,b   Presciutti, Otello ^c   Pelliccioli, Gianpiero ^c   Palumbo, Renato ^a   Gobbi, Gianni ^c   Chiarini, Pietro ^c   Palumbo, Barbara ^a   Tarducci, Roberto ^c   Senin, Umberto ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF FLORIDA   (United States)

^c SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INOSITOL; N ACETYLASPARTIC ACID; PROTON; TAURINE; ASPARTIC ACID; DIAGNOSTIC AGENT; DRUG DERIVATIVE; N-ACETYLASPARTATE; OXIME; TECHNETIUM COMPLEX;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN LEVEL; CASE CONTROL STUDY; DIFFERENTIAL DIAGNOSIS; MEMORY DISORDER; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ASPARTIC ACID; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIPPOCAMPUS; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMORY DISORDERS; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; OXIMES; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029665282     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb02428.x     Document Type: Article

References (27)

1. Haxby JV, Grady CL, Duara R., et al., Neocortical metabolic abnormalities precede non-memory cognitive deficits in early Alzheimer's dementia. Arch Neurol 1986; 43: 882-885.
2. Grady CI, Haxby JV, Horwitz B., et al., Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer Type. J Clin Exp Neuropsychol 1988; 10: 576-596.
3. Hyman BT, Van Hoesen GW, Damasio AR, et al., Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science 1984; 225: 1168-1170.
4. Ball MJ, Hachinski V., Fox A., A new definition of Alzheimer's disease: A hippocampal dementia. Lancet 1985; 82: 4531-4534.
5. Blessed G., Tomlinson BE, Roth M., The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114: 797-811.
6. Seab JP, Jagust WJ, Wong STS, et al., Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 1988; 8: 200-208.
7. Kesslak JP, Nalcioglu O., Cotman CW., Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991; 41: 51-54.
8. 99mTc-HMPAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987; 50: 1101-1109.
9. 99mTC-HMPAO: A SPECT study. J Cerebral Blood Flow Metab 1987; 11: 398-402.
10. 99m HMPAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med 1988; 29: 1507-1514.
11. Burns A., Philpot A., Costa D., et al., The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry 1989; 52: 248-253.
12. Upadhyaya AK, Abou-Saleh MT, Wilson K., et al., A study of depression in old age using single-proton emission computerised tomography. Br J Psychiatry 1990; 157 (suppl. 9): 76-81.
13. 99mTc-HMPAO SPECT-scan in Alzheimer's disease. Biol Psychiatry 1993; 33: 100-107.
14. Goldenberg G., Podreka I., Suess E., et al., The cerebral localization of neuropsychological impairment in Alzheimer's disease: A SPECT study. J Neurol 1989; 236: 131-138.
15. Hunter R., Gordon A., McLuskie R., et al., Gross regional cerebral hypofunction with normal CT scan in Creutzfeldt-Jacob disease. Lancet 1989; 333: 214-215.
16. Montaldi D., Brooks D., McColl J., et al., Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1990; 53: 33-38.
17. Miller BL, Moats RA, Shonk T., et al., Alzheimer disease: Depiction of increased cerebral myo-Inositol with proton MR Spectroscopy. Radiology 1993; 187: 433-437.
18. Moats RA, Ernst T., Shonk T., et al., Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 1994; 32: 110-115.
19. Crook T., Bartus RT, Ferris SH, et al., Age-associated memory impairment. Proposed diagnostic criteria and measures of clinical change. A report of the National Institute of Mental Health Work Group. Dev Neuropsychol 1986; 2: 261-271.
20. McKhann G., Drachman D., Folstein M., et al., Clinical diagnosis of Alzheimer's disease: Report of NINCDS-ADRDA work group under the auspicies of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
21. Folstein MF, Folstein SE, McHugh PR., A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
22. Klose U., In vivo proton spectoscopy in presence of Eddy currents. Magn Res Med 1990; 14: 26-30.
23. Press WH, Tenkolsky SA, Vetterling WT, et al., Numerical recipies in C. In: Modeling of Data, 2nd Ed. Cambridge, UK: Cambridge University Press, 1992, pp 656-706.
24. Weinstein HC, Haan J., Van Royen EA, et al., SPECT in the diagnosis of Alzheimer's disease and multi-infarct-dementia. Clin Neurol Neurosurg 1991; 93: 39-43.
25. Brayne C., Calloway P., Normal aging, impaired cognitive function, and senile dementia of the Alzheimer's type: A continuum? Lancet 1988; i: 1265-1267.
26. Dickson DW, Crystal LA, Mattace DM, et al., Identification of normal aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1991; 13: 179-189.
27. Reisberg B., Ferris SH, De Leon MJ, et al., The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136-1139.